Covid19

FDA Restricts J&J's COVID-19 Vaccine Over Blood Clot Risk – Voice of America

U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine because of the ongoing risk of rare but serious …

Read more at www.voanews.com

Show More

Related Articles

Back to top button